Versigent (NYSE:VGNT) Stock Rating Reaffirmed as “Outperform” by BNP Paribas Exane

Posted by Stanley Muller on Nov 5th, 2026

Versigent (NYSE:VGNT – Get Free Report)‘s stock had its “outperform” rating reaffirmed by equities research analysts at BNP Paribas Exane in a research note issued to investors on Thursday, Benzinga reports. They presently have a $54.00 price objective on the stock, down from their previous price objective of $55.00. BNP Paribas Exane‘s price target points to a potential upside of 31.98% from the stock’s current price.

A number of other research analysts also recently weighed in on VGNT. Wells Fargo & Company upped their price target on Versigent from $48.00 to $56.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 5th. Argus raised their price objective on Versigent from $50.00 to $54.00 and gave the company a “buy” rating in a research note on Thursday, August 13th. Evercore restated an “outperform” rating and set a $65.00 price objective on shares of Versigent in a report on Monday, August 10th. Royal Bank Of Canada upped their target price on Versigent from $52.00 to $53.00 and gave the stock an “outperform” rating in a research report on Monday, October 12th. Finally, TD Cowen increased their target price on Versigent from $49.00 to $58.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Versigent currently has a consensus rating of “Moderate Buy” and an average target price of $55.08.

Read Our Latest Report on VGNT

Versigent Stock Down 2.5%

Shares of NYSE VGNT traded down $1.05 during trading on Thursday, hitting $40.91. 340,164 shares of the company traded hands, compared to its average volume of 1,520,438. The business’s fifty day moving average is $45.08 and its 200 day moving average is $42.71. Versigent has a fifty-two week low of $26.34 and a fifty-two week high of $50.88. The firm has a market capitalization of $2.90 billion and a price-to-earnings ratio of 21.31. The company has a debt-to-equity ratio of 7.29, a quick ratio of 1.09 and a current ratio of 1.40.

Versigent (NYSE:VGNT – Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The company reported $1.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.79 by $0.12. The company had revenue of $2.45 billion for the quarter, compared to the consensus estimate of $2.42 billion. Equities research analysts predict that Versigent will post 7.23 earnings per share for the current fiscal year.

Insider Activity

In related news, Director Kevin Clark sold 74,130 shares of Versigent stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $45.67, for a total transaction of $3,385,517.10. Following the transaction, the director owned 124,849 shares of the company’s stock, valued at $5,701,853.83. The trade was a 37.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Insiders sold a total of 220,000 shares of company stock worth $10,065,848 over the last 90 days.

Institutional Investors Weigh In On Versigent

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Allianz Asset Management GmbH bought a new position in Versigent during the 2nd quarter valued at $20,602,000. HBK Investments L P bought a new stake in shares of Versigent in the 2nd quarter worth $14,439,000. Steamboat Capital Partners LLC bought a new stake in shares of Versigent in the 2nd quarter worth $10,385,000. VIRGINIA RETIREMENT SYSTEMS ET Al grew its stake in shares of Versigent by 321.3% in the 3rd quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 242,425 shares of the company’s stock worth $10,895,000 after acquiring an additional 184,888 shares in the last quarter. Finally, WINTON GROUP Ltd purchased a new stake in shares of Versigent in the second quarter valued at about $8,397,000.

Versigent News Summary

Here are the key news stories impacting Versigent this week:

Positive Sentiment: Q3 revenue was $2.45 billion, up 7.2% year over year, and adjusted EPS of $1.91 beat the $1.79 consensus estimate. Revenue also topped forecasts of $2.42 billion. Versigent Reports Third Quarter 2026 Results
Positive Sentiment: The company declared a quarterly dividend of $0.13 per share, payable December 17, equivalent to an annualized yield of about 1.2%. Dividend announcement
Neutral Sentiment: CFO Doug Ostermann is scheduled to speak at the RBC Capital Markets Global Industrials Conference on November 17; the announcement did not include new financial guidance. CFO to Participate in RBC Conference
Negative Sentiment: Despite the reported sales increase, adjusted net sales growth was approximately 1% year over year. That subdued underlying growth, alongside market pressures discussed on the earnings call, tempers the headline beat and may help explain the stock’s recent weakness. The company reported GAAP diluted EPS of $1.41, below its adjusted EPS figure. Versigent Earnings Call Shows Growth Despite Market Pressures

Versigent Company Profile

(Get Free Report)

Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.